Skip to main content
SpringerLink
Log in

Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al.

  • Letter
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Sairam S, Baethge BA, McNearney T (2003) Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies. Clin Rheumatol 22:24–29

    CAS  PubMed  Google Scholar 

  2. Erkan D, Yazici Y, Peterson MG, Sammaritano L, Lockshin MD (2002) A cross-sectional study of clinical thrombotic risk factors and preventive treatments in antiphospholipid syndrome. Rheumatology (Oxford) 41:924–929

    Google Scholar 

  3. Wilson WA, Gharavi AE, Koike T et al. (1999) International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 42:1309–1311

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Rheumatology, Hospital for Special Surgery, Weill Medical College of Cornell University, 535 East 70th Street, New York, NY 10021, USA

    Doruk Erkan & Yusuf Yazici

  2. Long Island College Hospital, State University of New York, Brooklyn, NY, USA

    Yusuf Yazici

Authors
  1. Doruk Erkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yusuf Yazici
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Doruk Erkan.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Erkan, D., Yazici, Y. Analysis of risk factors and comorbid diseases in the development of thrombosis in patients with anticardiolipin antibodies: comment on the article by Sairam et al.. Clin Rheumatol 22, 493 (2003). https://doi.org/10.1007/s10067-003-0777-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-003-0777-3

Keywords

Search

Navigation